Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met plus Advanced Non-Small Cell Lung Cancer: Stage 2

Basit Öğe Kaydı
dc.authoridBar, Jair/0000-0002-1224-3646
dc.authoridMoiseenko, Fedor/0000-0003-2544-9042
dc.authorwosidFilippova, Elena/AAE-2696-2022
dc.authorwosidBar, Jair/AAS-5743-2021
dc.authorwosidMoiseenko, Fedor/E-1775-2014
dc.contributor.authorGoldman, J.
dc.contributor.authorMoiseenko, F.
dc.contributor.authorCicin, I.
dc.contributor.authorHorinouchi, H.
dc.contributor.authorFilippova, E.
dc.contributor.authorBar, J.
dc.contributor.authorLu, S.
dc.date.accessioned2024-06-12T10:50:52Z
dc.date.available2024-06-12T10:50:52Z
dc.date.issued2021
dc.departmentTrakya Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpageS1097en_US
dc.identifier.issn1556-0864
dc.identifier.issn1556-1380
dc.identifier.issue10en_US
dc.identifier.startpageS1097en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/18163
dc.identifier.volume16en_US
dc.identifier.wosWOS:000709606500495en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofJournal Of Thoracic Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAdvanced Non-Small Cell Lung Canceren_US
dc.subjectTumor Biology - Immunoconjugates (Non-IO)en_US
dc.subjectDevelopmental Therapeutics-Molecularly Targeted Agentsen_US
dc.titleTelisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met plus Advanced Non-Small Cell Lung Cancer: Stage 2en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu